STANDARD BIOTOOLS INC.
Develops analytical systems for proteomic and multi-omic single-cell biological research.
LAB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US34385P1084
- LEI:
- Country:
- United States of America
- Address:
- 2 TOWER PLACE, 94080 SOUTH SAN FRANCISCO
- Website:
- https://www.standardbio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of measuring, testing, navigating and control equipment; watches and clocks
Description
Standard BioTools Inc., formerly Fluidigm Corp., is a life science company that develops, manufactures, and markets analytical systems for biological research. The company provides leading proteomic and multi-omic solutions that enable researchers to gain unique biological insights. Its core technologies include mass cytometry for high-parameter single-cell analysis, microfluidics via Integrated Fluidic Circuits (IFCs) for automating molecular biology in nanoliter volumes, and genomics platforms like the Biomark X9™ System for high-throughput real-time PCR and NGS library preparation. Standard BioTools serves the academic, translational, and clinical research communities, providing tools to accelerate discoveries in health and disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all STANDARD BIOTOOLS INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for STANDARD BIOTOOLS INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for STANDARD BIOTOOLS INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
